Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic

The novel coronavirus (CoV) pandemic is a serious threat for patients with cancer, who have an immunocompromised status and are considered at high risk of infections. Data on the novel CoV respiratory disease (coronavirus disease 2019 [COVID-19]) in patients with cancer are still limited. Unlike oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Indini, Alice, Rijavec, Erika, Ghidini, Michele, Cattaneo, Monica, Grossi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261437/
https://www.ncbi.nlm.nih.gov/pubmed/32534244
http://dx.doi.org/10.1016/j.ejca.2020.05.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261437/
https://www.ncbi.nlm.nih.gov/pubmed/32534244
http://dx.doi.org/10.1016/j.ejca.2020.05.017

Ejemplares similares